Healthcare & Life Sciences Industry Updates

Google News – EMA (biotech/pharma) External News

Seeking new social media horizons, EMA joins mass migration from X to Bluesky - Fierce Pharma

news.google.com · 08 Jul 2026

Google News – EMA (biotech/pharma) External News

WuXi Biologics Suzhou Center Passes EMA GMP Inspection - Contract Pharma

news.google.com · 08 Jul 2026

Google News – EMA (biotech/pharma) External News

MaaT Pharma Provides an Update on the Application for Marketing Authorization of MaaT013 (Xervyteg - Business Wire

news.google.com · 08 Jul 2026

Google News – FDA (biotech/pharma) External News

Can a chaotic FDA still deliver on faster drug development? - Pharma Voice

news.google.com · 08 Jul 2026

Google_site External News

Crucial choices in a global health crisis: Revealing the demand and willingness to pay for a hypothetical monkeypox vaccine - the PREVENT study - DR-NTU

news.google.com · 08 Jul 2026

Industry News External News

Hospital demands B30,000 deposit before emergency surgery - Bangkok Post

news.google.com · 08 Jul 2026

Google News – CDC External News

States, health organizations reject new CDC vaccine guidance - CIDRAP

news.google.com · 08 Jul 2026

Google News – FDA (biotech/pharma) External News

J‑Pharma Co., Ltd. and Uniphar Announce Advancement of Nanvuranlat into Phase 3 Clinical Development Following FDA Alignment and Initial Patient Enrollment - PMLiVE

news.google.com · 08 Jul 2026

Google News – FDA (biotech/pharma) External News

New FDA guidance could elevate pharma’s biosimilar market - BioPharma Dive

news.google.com · 08 Jul 2026

Google News – FDA (biotech/pharma) External News

Recon: FDA names new acting CDER, CBER heads; Supreme Court denies pharma’s challenge to IRA price negotiations - RAPS

news.google.com · 08 Jul 2026

Google News – EMA (biotech/pharma) External News

EMA fast tracks review of metastatic pancreatic cancer medicine - The Pharma Letter

news.google.com · 08 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA approves Vera’s dual-target Trutakna, setting up IgAN market battle with Novartis, Otsuka - Fierce Pharma

news.google.com · 08 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA approves Vera Therapeutics kidney disease treatment - STAT

news.google.com · 08 Jul 2026

Google News – FDA (biotech/pharma) External News

Aurobindo receives FDA OK for generic Vascepa - Drug Store News

news.google.com · 08 Jul 2026

Google News – FDA (biotech/pharma) External News

BioSpace: Opinion: The FDA must put biotech at its center or continue to cede early research to China - Massachusetts Biotechnology Council

news.google.com · 08 Jul 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Why healthcare providers are sidelining employees amid coronavirus pandemic

For adults with prediabetes, lifestyle intervention lowered risk of developing multiple chronic conditions

New Alzheimer’s blood test may tell when symptoms are around the corner

4 takeaways from MDUFA VI draft agreement

J&J wins FDA approval for dual-energy ablation catheter

Physicians’ wearable data use hampered by reimbursement, workflow barriers: survey

Vacancy: National Consultant (NO C) to strengthen maternal and newborn health systems.

Stanford Health Care Tri-Valley launches hospital expansion - Stanford Medicine

HHSC, UT Southwestern Medical Center celebrate opening of new psychiatric hospital in Dallas - UT Southwestern Medical

Hospital and health system leaders participate in Healthcare of Tomorrow Conference - American Hospital Association

HCA Healthcare hospitals earn 26 Press Ganey Human Experience Awards for patient experience - HCA Healthcare Today

CEO Nancy Brown named to Becker’s Hospital Review’s 2026 “Great Leaders in Healthcare” list - www.heart.org

Enhancing healthcare workers’ safety and well-being through a comprehensive qualitative analysis across hospital settings - Nature

Providers race to scale hospital-at-home before reimbursement changes - Modern Healthcare

One or Two Health Systems Controlled the Entire Market for Inpatient Hospital Care in Nearly Half of Metropolitan Areas in 2024 - KFF

How the hospital-at-home program offers alternative care as demand surges - investigatetv.com

Layoffs, closures tracker: Adventist Health cuts 132 jobs - Modern Healthcare

Experts: Cuts to federal student loans could hurt first generation students, healthcare industry - MPR News

Seeking new social media horizons, EMA joins mass migration from X to Bluesky - Fierce Pharma

WuXi Biologics Suzhou Center Passes EMA GMP Inspection - Contract Pharma

MaaT Pharma Provides an Update on the Application for Marketing Authorization of MaaT013 (Xervyteg - Business Wire

Can a chaotic FDA still deliver on faster drug development? - Pharma Voice

Crucial choices in a global health crisis: Revealing the demand and willingness to pay for a hypothetical monkeypox vaccine - the PREVENT study - DR-NTU

Hospital demands B30,000 deposit before emergency surgery - Bangkok Post

States, health organizations reject new CDC vaccine guidance - CIDRAP

J‑Pharma Co., Ltd. and Uniphar Announce Advancement of Nanvuranlat into Phase 3 Clinical Development Following FDA Alignment and Initial Patient Enrollment - PMLiVE

New FDA guidance could elevate pharma’s biosimilar market - BioPharma Dive

Recon: FDA names new acting CDER, CBER heads; Supreme Court denies pharma’s challenge to IRA price negotiations - RAPS

EMA fast tracks review of metastatic pancreatic cancer medicine - The Pharma Letter

FDA approves Vera’s dual-target Trutakna, setting up IgAN market battle with Novartis, Otsuka - Fierce Pharma

FDA approves Vera Therapeutics kidney disease treatment - STAT

Aurobindo receives FDA OK for generic Vascepa - Drug Store News

BioSpace: Opinion: The FDA must put biotech at its center or continue to cede early research to China - Massachusetts Biotechnology Council